interesting looking talk by michael berthold; prof in germany who developed Knime and used to work in pharma

A group of major pharmaceutical companies will share pooled data from failed clinical trials in an attempt to figure out what is going wrong in the studies and what can be done to improve drug development.
The data will be available to all the participating drug makers, as well as outside researchers with a valid scientific question, Dr. Cantillon said.

Shire's dependence on a drug for attention-deficit disorder that's scheduled to lose patent protection in April is tough a enough for pill for the British drug maker's holders to swallow. FDA decisions could inflict even more pain on the stock

Specialized management consulting to the pharmaceutical and biotech industries. Areas of expertise include Business Development, Research and Development, Strategic Marketing and Lifecycle Management.